Stereotactic ablative radiation therapy for the treatment of early-stage non-small-cell lung cancer: CEPO review and recommendations

Journal of Thoracic Oncology

Volumn 10, Issue 6, 2015, Pages 872-882

  Boily, Gino ^a   Filion, Édith ^b   Rakovich, George ^c   Kopek, Neil ^d   Tremblay, Lise ^e   Samson, Benoit ^f   Goulet, Stéphanie ^a   Roy, Isabelle ^g  

^a Institut National D'excellence en Santé et en Services Sociaux   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f HÔPITAL CHARLES LEMOYNE   (Canada)

^g Hôpital Cité de la Santé et Direction de Santé Publique de Laval   (Canada)

Author keywords

Inoperable patients; Non small cell lung cancer; Operable patients; Stereotactic ablative radiation therapy

Indexed keywords

CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; EARLY CANCER; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMOPTYSIS; HUMAN; INOPERABLE CANCER; LIFE EXPECTANCY; META ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PLEURA EFFUSION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE REDUCTION; RADIATION INJURY; RADIATION PNEUMONIA; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; REVIEW; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMATIC REVIEW; THERAPY EFFECT; THORAX PAIN; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; RADIOSURGERY; RADIOTHERAPY DOSAGE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE;

EID: 84938061323     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000524     Document Type: Review

References (65)

1. Canadian Cancer Society's Advisory Committee on Cancer Statistics Canadian Cancer Statistics 2014 2014 Toronto, ON Canadian Cancer Society
2. Girard N, Mornex F., [Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update]. Cancer Radiother 2011 15 522 526
3. Midthun DE, Jett JR., Update on screening for lung cancer. Semin Respir Crit Care Med 2008 29 233 240
4. Dahele M, Pearson S, Purdie T, Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center. J Thorac Oncol 2008 3 1332 1341
5. Loo BW Jr, Stereotactic ablative radiotherapy (SABR) for lung cancer: what does the future hold? J Thorac Dis 2011 3 150 152
6. Cook DJ, Guyatt GH, Laupacis A, Sackett DL., Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992 102 4 Suppl 305S 311S
7. Videtic GM, Reddy CA, Sorenson L., A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer. Support Care Cancer 2013 21 211 218
8. Shibamoto Y, Hashizume C, Baba F, Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. Cancer 2012 118 2078 2084
9. Taremi M, Hope A, Dahele M, Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. Int J Radiat Oncol Biol Phys 2012 82 967 973
10. Bral S, Gevaert T, Linthout N, Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial. Int J Radiat Oncol Biol Phys 2011 80 1343 1349
11. Baba F, Shibamoto Y, Ogino H, Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiat Oncol 2010 5 81
12. van Der Voort van Zyp NC, Prévost JB, van Der Holt B, Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2010 77 31 37
13. Timmerman R, Paulus R, Galvin J, Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010 303 1070 1076
14. Collins BT, Vahdat S, Erickson K, Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer. J Hematol Oncol 2009 2 1
15. Vahdat S, Oermann EK, Collins SP, Cyberknife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment. J Hematol Oncol 2010 3 6
16. Ricardi U, Filippi AR, Guarneri A, Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010 68 72 77
17. Timmerman R, McGarry R, Yiannoutsos C, Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006 24 4833 4839
18. Fakiris AJ, McGarry RC, Yiannoutsos CT, Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009 75 677 682
19. Baumann P, Nyman J, Hoyer M, Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer-a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 2008 88 359 367
20. Baumann P, Nyman J, Hoyer M, Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009 27 3290 3296
21. Koto M, Takai Y, Ogawa Y, A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2007 85 429 434
22. Scorsetti M, Navarria P, Facoetti A, Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer. Anticancer Res 2007 27 3615 3619
23. Hof H, Muenter M, Oetzel D, Stereotactic single-dose radiotherapy (radiosurgery) of early stage non-small-cell lung cancer (NSCLC). Cancer 2007 110 148 155
24. Hoyer M, Roed H, Hansen AT, Prospective study on stereotactic radiotherapy of limited stage non-small-cell lung cancer. Int J Rad Oncol Biol Phys 2006 66 S128 S135
25. Zimmermann FB, Geinitz H, Schill S, Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006 45 796 801
26. Yoon SM, Choi EK, Lee SW, Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol 2006 45 1108 1114
27. Nagata Y, Takayama K, Matsuo Y, Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005 63 1427 1431
28. Onishi H, Kuriyama K, Komiyama T, Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 2004 45 45 55
29. Fukumoto S, Shirato H, Shimzu S, Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas. Cancer 2002 95 1546 1553
30. Stanic S, Paulus R, Timmerman RD, No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. Int J Radiat Oncol Biol Phys 2014 88 1092 1099
31. Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O., Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Acta Oncol 2013 52 1552 1558
32. Shirvani SM, Jiang J, Chang JY, Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 2012 84 1060 1070
33. Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA., Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys 2011 81 e291 e297
34. Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P., Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 2010 95 32 40
35. Gauden S, Ramsay J, Tripcony L., The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 1995 108 1278 1282
36. Hayakawa K, Mitsuhashi N, Saito Y, Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 1999 26 137 142
37. Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW., Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996 34 297 302
38. Morita K, Fuwa N, Suzuki Y, Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol 1997 42 31 36
39. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR., Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998 40 149 154
40. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012 83 348 353
41. Grills IS, Hope AJ, Guckenberger M, A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol 2012 7 1382 1393
42. Takeda A, Kunieda E, Sanuki N, Aoki Y, Oku Y, Handa H., Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer. Lung Cancer 2012 77 77 82
43. Onishi H, Shirato H, Nagata Y, Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011 81 1352 1358
44. Hiraoka M, Nagata Y., Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience. Int J Clin Oncol 2004 9 352 355
45. Inoue T, Shimizu S, Onimaru R, Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. Int J Radiat Oncol Biol Phys 2009 75 683 687
46. Uematsu M, Shioda A, Suda A, Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001 51 666 670
47. Crabtree TD, Denlinger CE, Meyers BF, Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010 140 377 386
48. Varlotto J, Fakiris A, Flickinger J, Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 2013 119 2683 2691
49. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman B, Senan S., Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 2011 101 240 244
50. Robinson CG, DeWees TA, El Naqa IM, Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. J Thorac Oncol 2013 8 192 201
51. Verstegen NE, Oosterhuis JW, Palma DA, Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 2013 105 145 149
52. Grills IS, Mangona VS, Welsh R, Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010 28 928 935
53. van Baardwijk A, Tomé WA, van Elmpt W, Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review. Radiother Oncol 2012 105 145 149
54. Zhang J, Yang F, Li B, Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis. Int J Radiat Oncol Biol Phys 2011 81 e305 e316
55. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM., Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007 132 193 199
56. Donington J, Ferguson M, Mazzone P, Thoracic Oncology Network of American College of Chest Physicians; Workforce on Evidence-Based Surgery of Society of Thoracic Surgeons American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest 2012 142 1620 1635
57. Gewanter RM, Rosenzweig KE, Chang JY, ACR appropriateness criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent. Curr Probl Cancer 2010 34 228 249
58. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC., Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 143 5 Suppl e278S e313S
59. Lim E, Baldwin D, Beckles M, Guidelines on the radical management of patients with lung cancer. Thorax 2010 65 Suppl 3 iii1 27
60. Vansteenkiste J, De Ruysscher D, Eberhardt WE, Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013 24 iii1 27
61. National Comprehensive Cancer Network NCCN Guidelines: Non-Small Cell Lung Cancer 2014 version 2
62. Onishi H, Nagata S, Hiraoka M, When is SBRT best?. World Convention on Lung Cancer 2011
63. Onishi H, Araki T, Shirato H, Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004 101 1623 1631
64. Hof H, Hoess A, Oetzel D, Debus J, Herfarth K., Stereotactic single-dose radiotherapy of lung metastases. Strahlenther Onkol 2007 183 673 678
65. Soldà F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M., Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol 2013 109 1 7